376 related articles for article (PubMed ID: 12015893)
21. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
Nakajima A; Azuma M
Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
[TBL] [Abstract][Full Text] [Related]
22. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ
J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180
[TBL] [Abstract][Full Text] [Related]
23. IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86).
Ushio H; Tsuji RF; Szczepanik M; Kawamoto K; Matsuda H; Askenase PW
J Immunol; 1998 Mar; 160(5):2080-8. PubMed ID: 9498744
[TBL] [Abstract][Full Text] [Related]
24. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
[TBL] [Abstract][Full Text] [Related]
25. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.
Behrens L; Kerschensteiner M; Misgeld T; Goebels N; Wekerle H; Hohlfeld R
J Immunol; 1998 Dec; 161(11):5943-51. PubMed ID: 9834075
[TBL] [Abstract][Full Text] [Related]
26. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH
J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805
[TBL] [Abstract][Full Text] [Related]
27. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
28. B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy.
Schlienger K; Uyemura K; Jullien D; Sieling PA; Rea TH; Linsley PS; Modlin RL
J Immunol; 1998 Sep; 161(5):2407-13. PubMed ID: 9725237
[TBL] [Abstract][Full Text] [Related]
29. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R
Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092
[TBL] [Abstract][Full Text] [Related]
30. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells.
Rattis FM; Péguet-Navarro J; Staquet MJ; Dezutter-Dambuyant C; Courtellemont P; Redziniak G; Schmitt D
Eur J Immunol; 1996 Feb; 26(2):449-53. PubMed ID: 8617317
[TBL] [Abstract][Full Text] [Related]
31. Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene.
Gerstmayer B; Altenschmidt U; Hoffmann M; Wels W
J Immunol; 1997 May; 158(10):4584-90. PubMed ID: 9144470
[TBL] [Abstract][Full Text] [Related]
32. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
33. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Linsley PS; Aruffo A; Ledbetter JA
J Immunol; 1992 Oct; 149(8):2541-8. PubMed ID: 1383317
[TBL] [Abstract][Full Text] [Related]
34. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
35. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
36. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
[TBL] [Abstract][Full Text] [Related]
37. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.
Gajewski TF
J Immunol; 1996 Jan; 156(2):465-72. PubMed ID: 8543795
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts.
Pechhold K; Patterson NB; Craighead N; Lee KP; June CH; Harlan DM
J Immunol; 1997 May; 158(10):4921-9. PubMed ID: 9144510
[TBL] [Abstract][Full Text] [Related]
39. Alloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells.
Penninger JM; Timms E; Shahinian A; Jezo-Bremond A; Nishina H; Ionescu J; Hedrick SM; Mak TW
J Immunol; 1995 Oct; 155(8):3847-55. PubMed ID: 7561091
[TBL] [Abstract][Full Text] [Related]
40. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
